Recombinant Human TTLL3 Protein，GST

TTLL3 (tubulin tyrosine ligase-like 3) is an enzyme implicated in the post-translational modification of tubulin, a key component of the cytoskeleton in eukaryotic cells. Specifically, TTLL3 functions by adding a tyrosyl residue to the C-terminus of tubulin, a modification that is crucial for the stability and functionality of microtubules. The dynamics of microtubules are essential for various cellular processes, including mitosis, intracellular transport, and cell signaling. Research has indicated that aberrations in TTLL3 expression may be associated with several diseases, including cancer, where altered microtubule dynamics can lead to uncontrolled cell proliferation. Understanding the biochemical properties and regulatory mechanisms of TTLL3 is vital for elucidating its role in cellular homeostasis and disease pathology. Additionally, the potential of TTLL3 as a therapeutic target highlights the importance of studying its structure and function in detail. Recent advances in protein engineering and structural biology have enabled researchers to produce recombinant forms of TTLL3, facilitating in vitro studies on its enzymatic activity and interactions with tubulin and other cellular components. Investigating the TTLL3 recombinant protein will pave the way for further studies to develop strategies that modulate its activity, with implications for novel therapeutic approaches in diseases where microtubule dynamics are disrupted.